Exelixis (EXEL) Common Equity (2010 - 2026)
Exelixis' Common Equity was $1.84 billion in Q2 2027, down 9.3% from $2.03 billion a year earlier and down 4.8% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2026, Common Equity at Exelixis came in at $2.16 billion, down 3.7% from FY2025.
- Common Equity shows a five-year compound annual growth rate of -0.5% (FY2021 to FY2026).
- In earlier years, Common Equity was $2.24 billion in FY2025, $2.26 billion in FY2023 (-9.0%) and $2.49 billion in FY2022 (+12.6%).
- The Q2 2027 figure marks the lowest quarterly Common Equity since Q2 2021.
- Compared with a year earlier, Common Equity has declined for five straight quarters, with an average decline of 5.2% over the last six quarters.
- Per Business Quant data, EXEL's Common Equity in the three quarters before Q2 2027 was $1.94 billion (Q1 2027), $2.16 billion (Q4 2026) and $2.16 billion (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 1.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 1.84 Bn |
| Apr 3, 2026 | 1.94 Bn |
| Jan 2, 2026 | 2.16 Bn |
| Oct 3, 2025 | 2.16 Bn |
| Jul 4, 2025 | 2.03 Bn |
| Apr 4, 2025 | 2.13 Bn |
| Jan 3, 2025 | 2.24 Bn |
| Sep 27, 2024 | 2.28 Bn |
| Jun 28, 2024 | 2.12 Bn |
| Mar 29, 2024 | 2.13 Bn |
| Dec 29, 2023 | 2.26 Bn |
| Sep 29, 2023 | 2.35 Bn |
| Jun 30, 2023 | 2.53 Bn |
| Mar 31, 2023 | 2.56 Bn |
| Dec 30, 2022 | 2.49 Bn |
| Sep 30, 2022 | 2.49 Bn |
| Jul 1, 2022 | 2.39 Bn |
| Apr 1, 2022 | 2.29 Bn |
| Dec 31, 2021 | 2.21 Bn |
| Oct 1, 2021 | 2.11 Bn |
API Access
Exelixis Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();